![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Pharmacokinetics of Cobicistat-Boosted Elvitegravir Administered in Combination
with Methadone or Buprenorphine/Naloxone
|
|
|
Reported by Jules Levin
52nd ICAAC Sept 9-12 2012 SF
R Bruce1, P Winkle2, J Custodio3, X Yin3, M Rhee3, J Andrews3, B P Kearney3, and S Ramanathan3
1Yale University, New Haven, CT, US; 2Anaheim Clinical Trials, Anaheim, CA, US; 3Gilead Sciences, Inc., Foster City, CA, US
![IAAC1.gif](../images/091212/091212-1/IAAC1.gif)
![IAAC2.gif](../images/091212/091212-1/IAAC2.gif)
![IAAC3.gif](../images/091212/091212-1/IAAC3.gif)
![IAAC4.gif](../images/091212/091212-1/IAAC4.gif)
![IAAC5.gif](../images/091212/091212-1/IAAC5.gif)
![IAAC6.gif](../images/091212/091212-1/IAAC6.gif)
![IAAC7.gif](../images/091212/091212-1/IAAC7.gif)
![IAAC8.gif](../images/091212/091212-1/IAAC8.gif)
![IAAC9.gif](../images/091212/091212-1/IAAC9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|